April 2020 NDA/BLA Inspection Schedule by CFDI for NMPA: No. Acceptance number Company Products 1 CXSS1900005 Xinjiang Deyuan Bioengineering Human Immunnglnhlobulin (pH4) for Intravenous Injection 2 CXSS1700033 Shanxi Kangbao Biological Human coagulation factor Ⅷ 3 CYHS1900202 Chongqing Huapont Pharm Aminosalicylate Enteric-CoatedGranules 4 CXHS1800035 Yichang Humanwell Pharma Ramimazolam Besilate for Injection 5 CXSS1800029 Heibei Daan Pharma Human Immunnglnhlobulin (pH4) for Intravenous Injection 6 Y20190000075 Chongqing Huapont Kaisheng Pharm Aminosalicylate 7 CYSB1800230 Beijing Kawin Technology Recombinant Human Interferon α2b Injection 8 CYSB1800229 Beijing Kawin Technology Recombinant Human Interferon α2b Injection 9 CYSB1800228 Beijing Kawin Technology Recombinant Human Interferon α2b Injection 10 CYSB1800231 Beijing Kawin Technology Recombinant Human ...